years) was included. Symptoms included disfigurement (n = 27), haemorrhage (n = 4), and visual impairment (n = 2). The mean lesion size in the largest dimension was 2.9 cm. Lesions were located in the scalp (n = 4), orbit (n = 11), oral cavity (n = 3), lip (n = 3), face (n = 4), and neck (n = 2). The mean operating time was 201 minutes. Five patients required further embolisation during surgery; 18 patients had complete resection and nine had partial resection. The mean length of hospital stay was 4.7 days; 22 patients had uneventful recovery and the other five had minor complications. The mean follow-up period
iNtRODUCtiON
Vascular anomalies are difficult to treat. According to the International Society for the Study of Vascular Anomalies, 1,2 vascular anomalies are classified into vascular tumours and vascular malformations. The latter are further classified based on characteristics of channel (lymphatic, venous, or arteriovenous) and flow (slow flow, combined flow, or fast flow). These lesions are usually present at birth and continue to expand over time, 3 and result in physical disfigurement, profuse haemorrhage, and complications caused by the mass effect such as orbital or airway compression. Treatment options include sclerotherapy, laser photocoagulation, embolisation, and surgical resection. Sclerotherapy and laser photocoagulation have been successful for slow-flow vascular malformations, but require multiple procedures and may result in sclerosant-induced inflammation and swelling. [3] [4] [5] Laser therapy has been successful in superficial venous malformations, but has a high rate of recurrence. 4 Surgical resection is the most definitive treatment, but is technically demanding and dangerous due to the risk of profuse intra-operative bleeding, 3 particularly for vascular malformations in the head and neck.
Embolisation with n-butyl cyanoacrylate (n-BCA) followed by surgical resection significantly reduces intra-operative blood loss. n-BCA forms a firm consistency within the vascular malformations and results in a clear demarcation between the vascular malformations and healthy tissues.
6 Safety and efficacy of embolisation with n-BCA have been reported [6] [7] [8] [9] [10] [11] [12] ; most studies have described embolisation followed by delayed (days to weeks) surgical resection, and one study described same-stage embolisation (at the interventional radiology suite) followed by surgical resection (at the operation theatre). 6 In this article, we review the safety, efficacy, and outcome of singlestage embolisation with n-BCA followed by surgical resection for head and neck vascular malformations.
MEtHODS
This study was approved by the ethics committee of the Queen Elizabeth Hospital and conducted in compliance with the Declaration of Helsinki. We retrospectively reviewed the medical records of patients who underwent single-stage embolisation with n-BCA followed by surgical resection for vascular malformations at the head and neck region between October 2011 and April 2015 at Queen Elizabeth Hospital. Patients were referred to the multidisciplinary team for evaluation by interventional radiologists, paediatricians, and head and neck surgeons. Patients with imaging diagnosis of vascular tumours (e.g. haemangioma), vascular lesions with unclear diagnosis, vascular lesions not at the head or neck location, or use of other embolisation medium (e.g. contour particles) were excluded.
The hybrid procedure was performed under general anaesthesia in the endovascular operating room (Figure 1 ) by the multidisciplinary team. Preoperative ultrasonography, computed tomography, and magnetic resonance imaging were performed (Figures 2 and 3 ). Access to the vascular malformations was either by direct puncture with a 21-gauge butterfly needle or intraarterially by the Marathon Flow Directed Microcatheter (Covidien; Irvine [CA], USA) and Mirage 0.008 Guidewire (Covidien; Irvine [CA], USA), depending on lesion type, site, and vessel characteristics. Venous malformations were accessed by the direct approach, whereas arteriovenous malformations were preferably accessed by the intra-arterial approach, particularly when they were deep and had few supplying arteries.
Catheter position was confirmed with digital subtraction The n-BCA / lipiodol mixture was prepared at 25% to 50% concentration depending on lesion location, size, and presence of draining vessels. The mixture was then injected under fluoroscopic guidance until complete filling, with the needle or catheter removed on completion. External compression to the draining veins was given if necessary. Surgical resection was then performed in the same room without patient transfer. Dynamic computed tomography may be performed intra-operatively to guide resection. 
RESUltS
A total of 10 male and 17 female patients were included (Table) . Their mean age was 36.7 (range, 6-69) years and 20 patients had no prior treatment. Symptoms included disfigurement (n = 27, 100%), haemorrhage (n = 4, 15%), and visual impairment (n = 2, 7%). The mean lesion size in the largest dimension was 2.9 (range, 1.4-6.0) cm. Lesions were located in the temporal (n = 3) or suboccipital (n = 1) scalp, preseptal (n = 7) or postseptal / intraconal (n = 2) orbit, tongue (n = 2), buccal (n = 1), lip (n = 3), chin (n = 1), forehead (n = 1), cheek (n = 1), neck (n = 2), eyelid (n = 2), and submandibular (n = 1). 
(a) (b)
The mean operating time was 201 (range, 82-420) minutes. Five (19%) patients required further embolisation during surgery, with negligible intraoperative blood loss (<10 ml). In all, 18 (67%) patients had complete resection and nine (33%) had partial resection.
The mean length of hospital stay was 4.7 (range, 2-10) days. In all, 22 patients had uneventful recovery. One patient had an orbital haematoma that later subsided. One patient had mild wound infection that resolved with regular dressing. One patient had intra-operative supraorbital nerve damage that was repaired in the same setting, with minimal paraesthesia. One patient had ptosis that improved on recovery. One patient developed diplopia when the vision was recovered after treatment for an intra-orbital lesion.
The mean follow-up period was 20.6 (range, 1-43) months. All patients had good cosmetic outcome and symptom control. Two patients with orbital lesions had improved visual acuity. No patient had imaging or clinical evidence of recurrence; only one patient who underwent partial resection had recurrent symptoms but required no further treatment.
DiSCUSSiON
The risk of profuse intra-operative haemorrhage owing to hypervascularity of lesions is potentially fatal and renders surgical resection difficult when the operative field is obscured. Preoperative embolisation reduces intra-operative blood loss and enables a bloodless operative field for resection and reconstruction. The use of n-BCA enables formation of a 'cast' and easy demarcation of the vascular malformations and normal tissue to facilitate surgical excision. In addition, n-BCA / lipiodol is compatible with intra-operative fluoroscopy or dynamic computed tomography. n-BCA causes minimal inflammation and is not associated with discolouration of skin or combustion with diathermy.
In contrast, ethanol results in marked soft tissue inflammation and often precludes resection. Onyx (Medtronic; Minneapolis [MN] , USA] is expensive and associated with bluish discolouration of the overlying skin, 10 and intra-operative combustion when used with diathermy. 13 In addition, Onyx has better permeation to smaller arterioles than n-BCA; its infiltrating nature may lead to increased complications.
The safety and efficacy of embolisation with n-BCA have been reported. [6] [7] [8] [9] [10] [11] [12] Embolisation with n-BCA greatly reduces intra-operative blood loss and provides better visualisation of the surgical field. 8, 9 It enables delayed surgical resection of the cast within 10 to 15 days, as n-BCA results in intense soft tissue foreign body reaction that results in a pseudocapsule.
7 Singlestage embolisation with n-BCA (in the interventional radiology suite) followed by surgical excision (in the operating theatre) provides the benefit of a single episode of anaesthesia.
6 Acute inflammatory reaction related to n-BCA enables formation of a 'cast' and thus delayed surgery after soft tissue foreign body reaction does not seem to be necessary. Single-stage embolisation with n-BCA followed by surgical excision in the endovascular operating room allows multidisciplinary collaboration.
14 Despite elaborate preoperative imaging and planning, incomplete infiltration of n-BCA within the vascular malformations is not uncommon. In one study, 22% of patients required multiple episodes of embolisation, each under general anaesthesia, before surgery. 7 The endovascular operating room enables radiologists and surgeons to work simultaneously and allows multiple episodes of embolisation after surgical exposure. In our series, five (19%) patients required further embolisation during surgery. They usually had lesions that were larger and deeper with multiple compartments. Without multidisciplinary collaboration, these patients would have required several independent procedures, each under general anaesthesia, and possibly over a longer period. Digital subtraction angiography in the operating theatre enables intra-operative fluoroscopy and dynamic computed tomography to assess the residual glue cast and guide further resection.
CONClUSiONS
Single-stage embolisation with n-BCA followed by surgical excision by a multidisciplinary team in the endovascular operating room for management of vascular malformations of the head and neck region is safe and effective with minimal complications.
